Kits Cash And Equivalents vs Other Current Liab Analysis

KITS Stock

CAD 8.95 0.24 2.61%

Kits Eyecare financial indicator trend analysis is infinitely more than just investigating Kits Eyecare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kits Eyecare is a good investment. Please check the relationship between Kits Eyecare Cash And Equivalents and its Other Current Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kits Eyecare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cash And Equivalents vs Other Current Liab

Cash And Equivalents vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kits Eyecare Cash And Equivalents account and Other Current Liab. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Kits Eyecare's Cash And Equivalents and Other Current Liab is 0.94. Overlapping area represents the amount of variation of Cash And Equivalents that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Kits Eyecare, assuming nothing else is changed. The correlation between historical values of Kits Eyecare's Cash And Equivalents and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Equivalents of Kits Eyecare are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Cash And Equivalents i.e., Kits Eyecare's Cash And Equivalents and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cash And Equivalents

Other Current Liab

Most indicators from Kits Eyecare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kits Eyecare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kits Eyecare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Kits Eyecare's Issuance Of Capital Stock is very stable compared to the past year. As of the 3rd of December 2024, Sales General And Administrative To Revenue is likely to grow to 0.14, though Tax Provision is likely to grow to (642.2 K).

	2021	2022	2023	2024 (projected)
Interest Expense	1.5M	1.6M	1.6M	1.6M
Interest Income	67K	1.5M	585K	352.2K

Interest Expense Interest Income

Kits Eyecare fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Total Current Assets	Cash And Equivalents	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Current Liab	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Currrent Assets Other	Long Term Debt	Capital Surpluse
Total Assets		0.82	0.9	-0.9	0.88	0.83	0.88	-0.71	-0.25	0.96	0.29	0.87	0.92	0.85	0.9	0.89	-0.71	0.91	-0.9	0.85	0.9	0.82	-0.86	0.88	-0.56	0.85
Total Current Liabilities	0.82		0.49	-0.62	0.44	0.52	0.44	-0.72	-0.74	0.66	-0.23	0.99	0.54	0.48	0.55	0.56	-0.56	0.61	-0.75	0.47	0.49	0.58	-0.51	0.52	-0.2	0.6
Total Stockholder Equity	0.9	0.49		-0.92	0.99	0.89	0.99	-0.5	0.19	0.96	0.64	0.56	0.99	0.93	0.95	0.93	-0.71	0.94	-0.8	0.95	0.99	0.85	-0.94	0.96	-0.76	0.86
Retained Earnings	-0.9	-0.62	-0.92		-0.9	-0.98	-0.9	0.53	-0.06	-0.95	-0.58	-0.66	-0.94	-0.98	-0.99	-0.99	0.89	-0.98	0.93	-0.97	-0.95	-0.93	0.99	-0.96	0.77	-0.99
Cash	0.88	0.44	0.99	-0.9		0.87	1.0	-0.5	0.23	0.94	0.65	0.53	0.99	0.92	0.94	0.92	-0.65	0.91	-0.79	0.95	0.99	0.8	-0.93	0.94	-0.71	0.84
Other Assets	0.83	0.52	0.89	-0.98	0.87		0.87	-0.46	0.16	0.9	0.68	0.56	0.9	0.98	0.98	0.98	-0.93	0.95	-0.85	0.97	0.91	0.93	-0.99	0.95	-0.85	0.99
Cash And Short Term Investments	0.88	0.44	0.99	-0.9	1.0	0.87		-0.5	0.23	0.94	0.65	0.53	0.99	0.92	0.94	0.92	-0.65	0.91	-0.79	0.95	0.99	0.8	-0.93	0.94	-0.71	0.84
Net Receivables	-0.71	-0.72	-0.5	0.53	-0.5	-0.46	-0.5		0.51	-0.59	0.03	-0.78	-0.52	-0.49	-0.55	-0.54	0.31	-0.46	0.61	-0.5	-0.54	-0.33	0.5	-0.42	0.11	-0.49
Common Stock Shares Outstanding	-0.25	-0.74	0.19	-0.06	0.23	0.16	0.23	0.51		0.0	0.77	-0.69	0.14	0.19	0.12	0.1	-0.04	0.07	0.18	0.21	0.19	0.09	-0.18	0.19	-0.41	0.06
Inventory	0.96	0.66	0.96	-0.95	0.94	0.9	0.94	-0.59	0.0		0.47	0.72	0.98	0.91	0.94	0.93	-0.78	0.97	-0.91	0.92	0.96	0.9	-0.93	0.96	-0.69	0.91
Other Stockholder Equity	0.29	-0.23	0.64	-0.58	0.65	0.68	0.65	0.03	0.77	0.47		-0.18	0.58	0.7	0.64	0.63	-0.54	0.55	-0.27	0.72	0.64	0.56	-0.69	0.66	-0.84	0.58
Total Liab	0.87	0.99	0.56	-0.66	0.53	0.56	0.53	-0.78	-0.69	0.72	-0.18		0.62	0.54	0.62	0.62	-0.54	0.65	-0.79	0.53	0.57	0.58	-0.57	0.56	-0.2	0.63
Total Current Assets	0.92	0.54	0.99	-0.94	0.99	0.9	0.99	-0.52	0.14	0.98	0.58	0.62		0.93	0.95	0.94	-0.73	0.96	-0.86	0.95	0.99	0.86	-0.94	0.97	-0.72	0.89
Cash And Equivalents	0.85	0.48	0.93	-0.98	0.92	0.98	0.92	-0.49	0.19	0.91	0.7	0.54	0.93		0.99	1.0	-0.85	0.94	-0.84	1.0	0.96	0.88	-1.0	0.95	-0.82	0.96
Common Stock	0.9	0.55	0.95	-0.99	0.94	0.98	0.94	-0.55	0.12	0.94	0.64	0.62	0.95	0.99		1.0	-0.84	0.95	-0.88	0.99	0.97	0.88	-1.0	0.96	-0.78	0.97
Property Plant Equipment	0.89	0.56	0.93	-0.99	0.92	0.98	0.92	-0.54	0.1	0.93	0.63	0.62	0.94	1.0	1.0		-0.86	0.96	-0.89	0.99	0.96	0.89	-0.99	0.95	-0.78	0.97
Short Long Term Debt Total	-0.71	-0.56	-0.71	0.89	-0.65	-0.93	-0.65	0.31	-0.04	-0.78	-0.54	-0.54	-0.73	-0.85	-0.84	-0.86		-0.88	0.79	-0.82	-0.72	-0.95	0.87	-0.86	0.83	-0.94
Other Current Liab	0.91	0.61	0.94	-0.98	0.91	0.95	0.91	-0.46	0.07	0.97	0.55	0.65	0.96	0.94	0.95	0.96	-0.88		-0.91	0.94	0.94	0.96	-0.96	0.98	-0.78	0.96
Other Liab	-0.9	-0.75	-0.8	0.93	-0.79	-0.85	-0.79	0.61	0.18	-0.91	-0.27	-0.79	-0.86	-0.84	-0.88	-0.89	0.79	-0.91		-0.84	-0.85	-0.83	0.86	-0.84	0.49	-0.91
Net Tangible Assets	0.85	0.47	0.95	-0.97	0.95	0.97	0.95	-0.5	0.21	0.92	0.72	0.53	0.95	1.0	0.99	0.99	-0.82	0.94	-0.84		0.97	0.87	-1.0	0.96	-0.81	0.95
Property Plant And Equipment Net	0.9	0.49	0.99	-0.95	0.99	0.91	0.99	-0.54	0.19	0.96	0.64	0.57	0.99	0.96	0.97	0.96	-0.72	0.94	-0.85	0.97		0.83	-0.96	0.95	-0.72	0.89
Current Deferred Revenue	0.82	0.58	0.85	-0.93	0.8	0.93	0.8	-0.33	0.09	0.9	0.56	0.58	0.86	0.88	0.88	0.89	-0.95	0.96	-0.83	0.87	0.83		-0.9	0.95	-0.85	0.94
Net Debt	-0.86	-0.51	-0.94	0.99	-0.93	-0.99	-0.93	0.5	-0.18	-0.93	-0.69	-0.57	-0.94	-1.0	-1.0	-0.99	0.87	-0.96	0.86	-1.0	-0.96	-0.9		-0.97	0.82	-0.97
Non Currrent Assets Other	0.88	0.52	0.96	-0.96	0.94	0.95	0.94	-0.42	0.19	0.96	0.66	0.56	0.97	0.95	0.96	0.95	-0.86	0.98	-0.84	0.96	0.95	0.95	-0.97		-0.85	0.94
Long Term Debt	-0.56	-0.2	-0.76	0.77	-0.71	-0.85	-0.71	0.11	-0.41	-0.69	-0.84	-0.2	-0.72	-0.82	-0.78	-0.78	0.83	-0.78	0.49	-0.81	-0.72	-0.85	0.82	-0.85		-0.79
Capital Surpluse	0.85	0.6	0.86	-0.99	0.84	0.99	0.84	-0.49	0.06	0.91	0.58	0.63	0.89	0.96	0.97	0.97	-0.94	0.96	-0.91	0.95	0.89	0.94	-0.97	0.94	-0.79

Click cells to compare fundamentals

Kits Eyecare Account Relationship Matchups

Kits Eyecare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.4M	54.7M	90.9M	93.9M	87.6M	61.7M
Total Current Liabilities	30.6M	34.6M	16.8M	24.4M	24.5M	22.1M
Total Stockholder Equity	6.2M	(573K)	54.8M	53.7M	51.4M	26.4M
Retained Earnings	53K	(6.5M)	(21.1M)	(25.7M)	(27.9M)	(26.5M)
Cash	3.4M	2.3M	20.5M	18.8M	16.0M	10.5M
Other Assets	5K	210K	3.6M	5.1M	5.9M	6.2M
Cash And Short Term Investments	3.4M	2.3M	20.5M	18.8M	16.0M	10.5M
Net Receivables	845K	1.1M	861K	917K	1.8M	980.3K
Long Term Debt Total	14.7M	19.1M	19.3M	15.7M	18.1M	12.6M
Liabilities And Stockholders Equity	53.4M	54.7M	90.9M	93.9M	87.6M	61.7M
Inventory	2.8M	5.8M	13.5M	16.4M	15.4M	8.8M
Other Stockholder Equity	(3.4M)	(6.9M)	1.9M	2.9M	3.0M	3.2M
Total Liab	47.2M	55.2M	36.2M	40.2M	36.2M	35.3M
Total Current Assets	7.2M	10.3M	35.7M	37.0M	34.0M	21.4M
Cash And Equivalents	3.4M	2.3M	20.5M	18.8M	21.6M	22.7M
Short Term Debt	23.3M	21.5M	3.6M	3.7M	3.7M	6.4M
Property Plant Equipment	1.1M	1.6M	10.9M	10.0M	11.5M	12.1M
Accounts Payable	5.0M	9.6M	8.4M	14.5M	12.9M	9.2M
Non Current Assets Total	46.2M	44.3M	55.2M	56.9M	53.7M	47.0M
Good Will	37.2M	36.4M	36.3M	38.8M	37.9M	34.2M
Non Current Liabilities Total	16.6M	20.7M	19.3M	15.7M	11.7M	15.4M
Capital Lease Obligations	675K	1.0M	6.9M	6.3M	5.7M	3.8M
Net Invested Capital	29.4M	20.7M	70.9M	66.9M	61.2M	45.7M
Net Working Capital	(23.4M)	(24.3M)	18.9M	12.6M	9.5M	9.9M

Other Information on Investing in Kits Stock

Balance Sheet is a snapshot of the financial position of Kits Eyecare at a specified time, usually calculated after every quarter, six months, or one year. Kits Eyecare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kits Eyecare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kits currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kits Cash And Equivalents vs Other Current Liab Analysis

Cash And Equivalents vs Other Current Liab

Cash And Equivalents vs Other Current Liab Correlation Analysis

Correlation Coefficient

Cash And Equivalents

Other Current Liab

Kits Eyecare fundamental ratios Correlations

Kits Eyecare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Kits Eyecare fundamental ratios Accounts

Other Information on Investing in Kits Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant Equipment	+ 1.0	Cash And Equivalents
Net Tangible Assets	+ 1.0	Cash And Equivalents
Property Plant Equipment	+ 1.0	Common Stock
Total Liab	+ 0.99	Total Current Liabilities
Cash	+ 0.99	Total Stockholder Equity

Net Debt	- 1.0	Net Tangible Assets
Net Debt	- 1.0	Common Stock
Net Debt	- 1.0	Cash And Equivalents
Net Debt	- 0.99	Property Plant Equipment
Net Debt	- 0.99	Other Assets
Capital Surpluse	- 0.99	Retained Earnings